Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Registration opens October 19th at 9:00. As part of the Madrid Science and Innovation Week, the RESILIENCE H2020 project invites young people aged 14 to 18 to participate in a free workshop exploring the fascinating connection between heart health and cancer. Through this educational activity, participants will discover how cardiovascular diseases and cancer are linked, […]
